CORCEPT THERAPEUTICS INC Interest and Other Income
CORCEPT THERAPEUTICS INC (CORT) reported Interest and Other Income of $6.83 million for the 167-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2014-03-14
- CORCEPT THERAPEUTICS INC interest and other income for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest and other income for the quarter ending 2011-09-30 was $3.00K, a 25.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest and other income for the quarter ending 2011-06-30 was -$1.00K, a 100.13% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest and other income for the quarter ending 2011-03-31 was $2.00K.
- CORCEPT THERAPEUTICS INC interest and other income for fiscal 2011 was $3.00K, a 99.80% decline from fiscal 2010.
- CORCEPT THERAPEUTICS INC interest and other income for fiscal 2010 was $1.50M, a 1381.19% increase from fiscal 2009.
- CORCEPT THERAPEUTICS INC interest and other income for fiscal 2009 was $101.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month | Interest and Other Income 158 month | Interest and Other Income 161 month | Interest and Other Income 164 month | Interest and Other Income 167 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $6.83M 10-Q · filed 2012-05-10 | |||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $3.00K derived: sum of 2 quarters · filed 2014-03-14 | $2.00K derived: sum of 3 quarters · filed 2014-03-14 | $3.00K 10-K · filed 2014-03-14 | $6.83M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | $3.00K 10-Q · filed 2012-11-08 | $2.00K derived: sum of 2 quarters · filed 2012-11-08 | $3.00K 10-Q · filed 2012-11-08 | $742.00K derived: sum of 4 quarters · filed 2013-03-15 | $6.83M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | -$1.00K 10-Q · filed 2012-08-09 | $1.00K 10-Q · filed 2012-08-09 | $739.00K derived: sum of 3 quarters · filed 2013-03-15 | $743.00K derived: sum of 4 quarters · filed 2013-03-15 | $6.82M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | $2.00K 10-Q · filed 2012-05-10 | $740.00K derived: sum of 2 quarters · filed 2013-03-15 | $744.00K derived: sum of 3 quarters · filed 2013-03-15 | $1.50M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2010-12-31 | $738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $742.00K derived: sum of 2 quarters · filed 2013-03-15 | $1.50M derived: sum of 3 quarters · filed 2013-03-15 | $1.50M 10-K · filed 2013-03-15 | ||||
| 2010-09-30 | $4.00K 10-Q · filed 2011-11-08 | $757.00K derived: sum of 2 quarters · filed 2011-11-08 | $758.00K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $753.00K 10-Q · filed 2011-08-09 | $755.00K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $101.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |